Stock SAGENT PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

MarketScreener Editorial Features Sagent Pharmaceuticals Inc

Equities

US7866921031

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Sagent Pharmaceuticals Inc
2016 Allergan : Teva, Allergan win U.S. antitrust approval for generics deal RE

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Sagent Pharmaceuticals Inc
  5. MarketScreener Editorial Features